Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AB, AbbVie, acquiree, AICPA, Alcon, Alligator, AMD, arbitration, award, awarded, bankrupt, bargain, barrier, Bayesian, Beovu, bilirubin, Biocytogen, Biopharma, Bioscience, bleeding, BOIN, Celldex, chosen, classification, cohort, construed, counterparty, CRS, degeneration, DESC, diabetic, dispute, disputed, edema, EIP, elevated, equitable, Eucure, Fc, fever, forfeited, forfeiture, forma, fourth, freestanding, gave, Goodwill, hepatic, house, ideal, intangible, Interval, liver, Lyvgen, macular, month, move, multiplied, neovascular, noncontrolling, optic, PD, PK, pro, protest, provisional, rabbit, ratio, relief, reorganization, repositioning, Roche, shareholder, splice, Steering, sum, unallocated, variant, visual, voluntarily, warrant, wet
Removed:
allocate, deployed, leveraging, routine, understanding
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view